Stephen Villano
Nessuna posizione attualmente
Profilo
Stephen Villano worked as Vice President of Clinical Research & Development at Shire ViroPharma, Inc. and as Vice President of Clinical & Medical Affairs at Paratek Pharmaceuticals, Inc. He holds a doctorate degree from The Johns Hopkins University.
Precedenti posizioni note di Stephen Villano
| Società | Posizione | Fine |
|---|---|---|
| PARATEK PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Corporate Officer/Principal | - |
Formazione di Stephen Villano
| The Johns Hopkins University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PARATEK PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Health Technology |
- Borsa valori
- Insiders
- Stephen Villano
